The invention provides a series of bioactive small molecules that target expanded r repeats, termed rexp, that causes Fragile X-associated Tremor Ataxia Syndrome. The deployable jaws retraction device includes a jaw assembly having two or more jaws joined at one end and a retention device to maintain the jaws of the closed condition about a target body organ. 5 times the thickness of the at least one first current collector.